Publication | Open Access
Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability
75
Citations
20
References
2013
Year
Heart FailureCardiovascular DiseaseMed13l Further DelineateDosage ChangesPediatric Heart DiseasePharmacologyCongenital Heart DefectPharmacotherapyMedicineCardiology
| Year | Citations | |
|---|---|---|
Page 1
Page 1